Final Summary of Safety Evaluation Study on Active Ingredient Combination

A phase summary of the safety evaluation study on the active ingredient combination, supported by the team from the Center for Safety Evaluation at Hangzhou Medical College, has been completed. Conducted according to international standards, the results show a safety dose window of 15–67.5 times for the active ingredient combination, with no signals of genetic or reproductive toxicity observed.

The data provide a scientific reference for the long-term use of Vitasoy products among rehabilitation patients and middle-aged to elderly populations. Follow-up research will continue.